What if your body had a 'cost of being alive' score? Deepinder Goyal reveals Temple's new discovery

In the quest for better health insights, wearable technology has long depended on metrics like heart rate and sleep patterns. However, Deepinder Goyal, co-founder of Zomato, has introduced a groundbreaking discovery through his health-tech initiative, Temple. This innovation centers around a biomarker named "Entropy," which is poised to redefine how we perceive our body's metabolic cost in real time. Goyal recently shared details about this discovery on X (formerly known as Twitter), emphasizing that Entropy measures the energy expenditure linked to simply being alive. This unique metric is exclusively detectable in the temple area of the head and provides updates every second on a scale from 1 to 250. "The Temple team has made a breakthrough in measuring the real-time cost of being alive," Goyal stated, underscoring the novel approach. The readings from Entropy vary significantly; lower values indicate restful states, while higher scores suggest vigorous physical activity. Notably, experienced meditators have shown the lowest Entropy scores during deep practice, whereas elite athletes have registered the highest during peak performance. Temple claims that Entropy is responsive to a multitude of factors including sleep quality, stress levels, exercise intensity, caffeine intake, dietary habits, and even environmental conditions. This versatility positions Entropy as a more holistic measure of metabolic demand compared to traditional heart-rate metrics. In trials involving over 100 cardio sessions, Entropy demonstrated a correlation coefficient of 0.93 with readings from a laboratory-grade calorimeter, significantly outperforming the 0.55 correlation seen with heart rate. Two critical components of Entropy have been defined: Entropy Maxima and Entropy Minima. Entropy Maxima reflects a person's peak metabolic state during exertion, indicating their physical capabilities and resilience. Conversely, Entropy Minima measures the lowest metabolic cost during rest, which Goyal suggests could be linked to longevity. Lower resting metabolic rates have been associated with a longer lifespan across various species, highlighting the importance of cultivating this aspect through healthy lifestyle choices. While the scientific community has yet to fully validate these claims, Temple’s announcement signifies a bold step towards enhancing personal health monitoring. Goyal describes tracking Entropy as a transformative experience, potentially revealing insights that traditional health metrics overlook. Although the company has not set a public release date for this technology, Goyal indicated that further refinement is planned before it becomes available to the wider public. If substantiated by future research, Entropy could significantly enhance our understanding of real-time physiological states, marking a shift from mere activity tracking to a deeper exploration of health dynamics.